centene chief medical officer

Previously he served as Senior Vice President and Chief Information Officer for Humana, where he spent more than two decades in various technology and operational leadership roles. corporate governance. Previously, he was President and CEO of Fidelis Care where he led oversight across all divisions of Fidelis Care. Over the next year, Mr. Layton will continue to play a pivotal role in developing and expanding key strategic partnerships for Centene and driving the Company's business development strategy. Prior to that, he was Chairman, President, and CEO of HealthMarkets, Inc., one of the largest health insurance agencies and supplemental insurance companies in the U.S. HealthMarkets was acquired by UnitedHealth Group in 2019. You should not place undue reliance on any forward-looking statements, as actual results may differ materially from projections, estimates, or other forward-looking statements due to a variety of important factors, variables and events including, but not limited to: our ability to accurately predict and effectively manage health benefits and other operating expenses and reserves, including fluctuations in medical utilization rates due to the ongoing impact of COVID-19; our ability to maintain or achieve improvement in the Centers for Medicare and Medicaid Services (CMS) Star ratings and maintain or achieve improvement in other quality scores in each case that can impact revenue and future growth; the risk that the election of new directors, changes in senior management, and any inability to retain key personnel may create uncertainty or negatively impact our ability to execute quickly and effectively; uncertainty as to the expected financial performance of the combined company following the recent completion of the acquisition of Magellan Health, Inc. (the Magellan Acquisition); the possibility that the expected synergies and value creation from the Magellan Acquisition or the acquisition of WellCare Health Plans, Inc. (the WellCare Acquisition) (or other acquired businesses) will not be realized, or will not be realized within the respective expected time periods; disruption from the integration of the Magellan Acquisition or from the integration of the WellCare Acquisition; unexpected costs, or similar risks, from other acquisitions or dispositions we may announce or complete from time to time, including potential adverse reactions or changes to business relationships with customers, employees, suppliers or regulators, making it more difficult to maintain business and operational relationships; the risk that the closing conditions, including applicable regulatory approvals, for the pending disposition of Magellan Specialty Health may be delayed or not obtained; impairments to real estate, investments, goodwill and intangible assets; a downgrade of the credit rating of our indebtedness; competition; membership and revenue declines or unexpected trends; changes in healthcare practices, new technologies, and advances in medicine; increased healthcare costs; changes in economic, political or market conditions; changes in federal or state laws or regulations, including changes with respect to income tax reform or government healthcare programs as well as changes with respect to the Patient Protection and Affordable Care Act and the Health Care and Education Affordability Reconciliation Act (collectively referred to as the ACA) and any regulations enacted thereunder that may result from changing political conditions, the current administration or judicial actions; rate cuts or other payment reductions or delays by governmental payors and other risks and uncertainties affecting our government businesses; our ability to adequately price products; tax matters; disasters or major epidemics; changes in expected contract start dates; provider, state, federal, foreign and other contract changes and timing of regulatory approval of contracts; the expiration, suspension, or termination of our contracts with federal or state governments (including, but not limited to, Medicaid, Medicare, TRICARE or other customers); the difficulty of predicting the timing or outcome of legal or regulatory proceedings or matters, including, but not limited to, our ability to resolve claims and/or allegations made by states with regard to past practices, including at Envolve Pharmacy Solutions, Inc. (Envolve), as our pharmacy benefits manager (PBM) subsidiary, within the reserve estimate we previously recorded and on other acceptable terms, or at all, or whether additional claims, reviews or investigations relating to our PBM business will be brought by states, the federal government or shareholder litigants, or government investigations; the timing and extent of benefits from our value creation strategy, including the possibility that the benefits received may be lower than expected, may not occur, or will not be realized within the expected time periods; challenges to our contract awards; cyber-attacks or other privacy or data security incidents; the exertion of management's time and our resources, and other expenses incurred and business changes required in connection with complying with the undertakings in connection with any regulatory, governmental or third party consents or approvals for acquisitions or dispositions; any changes in expected closing dates, estimated purchase price and accretion for acquisitions or dispositions; restrictions and limitations in connection with our indebtedness; the availability of debt and equity financing on terms that are favorable to us; inflation; foreign currency fluctuations; and risks and uncertainties discussed in the reports that Centene has filed with the Securities and Exchange Commission. Sarah London, Chief Executive Officer; and Drew Asher, Executive Vice . Centene.com uses cookies. The Centers for Disease Control and Prevention (CDC) has the most up-to-date information on the COVID-19 vaccine, including clinical resources and state-related guidance. Ms. London previously served as Vice President of Client Services & Operations with Humedica, a venture-backed healthcare data and analytics company acquired by Optum in 2013. Centene (the Company, our, or we) intends such forward-looking statements to be covered by the safe-harbor provisions for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995, and we are including this statement for purposes of complying with these safe-harbor provisions. healthcare services. Financial and other information about Centene is routinely posted and is accessible on Centene's investor relations website, https://investors.centene.com/. Centene offers affordable and high-quality products to nearly 1 in 15 individuals across the nation, including Medicaid and Medicare members (including Medicare Prescription Drug Plans) as well as individuals and families served by the Health Insurance Marketplace and the TRICARE program. ST. LOUIS, Dec. 14, 2022 /PRNewswire/ -- Centene Corporation (NYSE: CNC) announced today leadership changes and senior management appointments to position the Company for its next stage of growth. If we keep frontline workers safe and healthy, they can continue providing vital services for those in need without adding strain to an already overwhelmed healthcare system. Transforming Communities, Health & Wellness. These forward-looking statements reflect our current views with respect to future events and are based on numerous assumptions and assessments made by us in light of our experience and perception of historical trends, current conditions, business strategies, operating environments, future developments and other factors we believe appropriate. Dr. Ken Yamaguchi, Centene Executive Vice President & Chief Medical Officer, has firsthand experience with the COVID-19 vaccine. Brent Layton has more than 30 years of experience with increasing responsibility in the healthcare and public policy sectors, with particular expertise in creating, scaling, and operating business in a highly regulated environment. All statements, other than statements of current or historical fact, contained in this press release are forward-looking statements. Centene Chief Medical Officer Salaries | Glassdoor Centeneoffers affordable and high-quality products to nearly 1 in 15 individuals across the nation, including Medicaid and Medicare members (including Medicare Prescription Drug Plans) as well as individuals and families served by theHealth Insurance Marketplace, the TRICARE program, and individuals in correctional facilities. Hispanic Heritage Month: Meet Dr. Sandra Guerra - Centene Dave joined Fidelis in 1999 as Director of Strategic Planning and Development and held positions of increasing responsibility during his tenure from Vice President, Senior Vice President of Operations, Senior Vice President and Chief Administrative Officer, and Executive Vice President and Chief Operating Officer culminating in leading the organization. Margaret-Mary Wilson Minnetonka-based health insurer UnitedHealth Group said that it has promoted Dr. Margaret-Mary Wilson from executive vice president and associate chief medical officer to. Brent Layton becomes Senior Advisor to the CEO, Dave Thomas becomes Chief Executive Officer of Markets and Medicaid, Additionally, Company appoints Alice H. Chen, MD, MPH as Chief Health Officer and Brian LeClaire, MBA, PhD, as Chief Information Officer. He served as CEO of Secure Horizons, a division of UnitedHealth Group and the nation's largest Medicare Advantage insurer. The Company takes a local approach with local brands and local teams to provide fully integrated, high-quality, and cost-effective services to government-sponsored and commercial healthcare programs, focusing on under-insured and uninsured individuals. Mr. Layton received his bachelor's degree from the University of Georgia. Centenefocuses on long-term growth and value creation as well as the development of its people, systems, and capabilities so that it can better serve its members, providers, local communities, and government partners. The health of individuals drives our focus on the environment, removing social barriers to health, and prioritizing responsible corporate governance. Transforming the health of the community, one person at a time. ST. LOUIS, March 22, 2022 /PRNewswire/ --Centene Corporation (NYSE: CNC) announced today that Sarah London, Vice Chairman of Centene, has been appointed Chief Executive Officer, effective immediately, succeeding Michael Neidorff. Brent Layton has more than 30 years of experience with increasing responsibility in the healthcare and public policy sectors, with particular expertise in creating, scaling, and operating business in a highly regulated environment. verdade. ST. LOUIS, April 20, 2023 /PRNewswire/ -- Centene Corporation (NYSE: CNC) announced today it has named Anika Gardenhire RN, BSN, MMCI as its Chief Customer Experience Officer (CXO). Most COVID-19 vaccines require two injections; the first starts building protection and the second is given a few weeks later. Because of the language barrier, many Hispanic Kentuckians may have already faced health access issues, which is one of the reasons why the virus has had a disproportionate impact in this community, but Dr. Guerra has also noticed the impact that misinformation found on social media can have on compounding disparities. Alice Hm Chen - Chief Health Officer - Centene Corporation - LinkedIn Centene said it net income increased 33% year-over-year, to $1.13 billion, or $2.11 earnings per share, on revenues of $38.8 billion, driven by increased exchange revenue and lower medical expenses. Founded in 1933 and based in Eugene, OR, with offices in Oregon, Idaho and Montana, PacificSource serves ~ 260,000 members (Commercial . Dr. Chen received a Bachelor of Science in Environmental Biology from Yale University and has a Doctor of Medicine from the Stanford University School of Medicine. Centenefocuses on long-term growth and value creation as well as the development of its people, systems, and capabilities so that it can better serve its members, providers, local communities, and government partners. Prior to joining HealthMarkets, Mr. Fasola spent nearly twenty years in executive leadership roles at UnitedHealth Group and Humana. Dr. Chen was also a professor of medicine at the University of California San Francisco School of Medicine, based at the Zuckerberg San Francisco General Hospital, where she served as its Chief Integration Officer and founding director of the eConsult program. All forward-looking statements included in this press release are based on information available to us on the date hereof. Centene offers affordable and high-quality products to nearly 1 in 15 individuals across the nation, including Medicaid and Medicare members (including Medicare Prescription Drug Plans) as well as individuals and families served by theHealth Insurance Marketplace, the TRICARE program, and individuals in correctional facilities. Prior to that he was a Vice President of Product Development at Alltel, a wireless service provider acquired by Verizon Wireless. Our local approach allows us to help members access high-quality, culturally sensitive At Arsenal, he led information technology due diligence, advisory and oversight for the firm's healthcare sector, and aided portfolio companies in the development and delivery of their technology strategy and value capture initiatives. PacificSource Health Plans. Wenn Equipped with deep experience in operations spanning a career of nearly three decades, Mr. Murray will be critical to Centene's efforts in value creation, quality, and core business operations. Brent Layton, Senior Advisor to CEO, Centene Corporation. Nous sommes dsols pour la gne occasionne. I'm excited by the tremendous opportunity to leverage the size and scale of this Company to create true, sustaining value for our members, state partners, employees and shareholders.". Prior to joining Humedica, Ms. London was part of the team that launched Accretive Health's Quality & Total Cost of Care business, providing end-to-end population health strategy and operational consulting to leading medical centers around the country. . Prior to his roles at Magellan, Mr. Murray served as President of PrimeWest Health, a Dallas-based company which supports physician shift to value-based care and Chief Executive Officer of LifeCare HealthPartners, a Dallas-based hospital system. Mr. Neidorff remains on a previously announced medical leave of absence from his position on the Board of the Company. Centene Appoints Sarah London As Chief Executive Officer Conditions. Dr. Chen is responsible for Centene's strategies, policies, and programs in support of improving population health for Centene's more than 26 million members. Mr. Neidorff remains on a previously announced medical leave of absence from his position on the Board of the Company. This list of important factors is not intended to be exhaustive.

International Lacrosse Coaching Jobs, David Blanton Realtree Age, Articles C